Eastern Virginia Medical School

Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments

Retrieved on: 
Wednesday, February 28, 2024
ASRS, Senior, Paris Diderot University, SAB, Reno 1868 FC, Growth, Visual acuity, University, DED, Telecanthus, Organization, Principal, Teaching hospital, Retina, Anthropology, Diabetic retinopathy, Therapy, OCS, Inflammation, CSO, DME, American Academy, Simmons University, M.A, Clinical research, ASCRS, Society, Cerebral edema, Eastern Virginia Medical School, Patient, Partner (business rank), Medicine, Pharmaceutical industry

In-person and virtual R&D Day today from 9:00 AM to 11:00 AM EST at the InterContinental New York Barclay.

Key Points: 
  • In-person and virtual R&D Day today from 9:00 AM to 11:00 AM EST at the InterContinental New York Barclay.
  • “2024 promises to be another exciting year for Oculis as we advance our late-stage clinical development programs.
  • I am certain that the extensive experience each of them brings will be invaluable to Oculis,” said Riad Sherif, M.D., Chief Executive Officer of Oculis.
  • Oculis also announced today key executive appointments to bolster its leadership and scientific advisory teams.

Wilford K. Gibson, MD, FAAOS, Named Second Vice President of American Academy of Orthopaedic Surgeons

Retrieved on: 
Wednesday, February 14, 2024
Robotics, Private practice, SAN, Division, USS Nassau, MD, Medical college, Tampa General Hospital, National Defense Service Medal, Meritorious Unit Commendation, Hip, NMCP, Old Dominion University, BOC, Orthopedic surgery, Outline of health sciences, Annual general meeting, Eastern Virginia Medical School, Patient, Knee, Commendation Medal, Trauma, National security, Political action committee, American Academy, Nursing

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- Virginia surgeon Wilford K. Gibson, MD, FAAOS, was appointed second vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.

Key Points: 
  • SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- Virginia surgeon Wilford K. Gibson, MD, FAAOS, was appointed second vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.
  • His role is the first in a four-year term of volunteer service during which he will serve as president of the AAOS in 2026.
  • He will assume the second vice president position following the AAOS 2024 Annual Meeting this week in San Francisco.
  • A former president of the Virginia Orthopaedic Society, he received the society's 2014 President's Award and 2015 Career Lifetime Achievement Award.

Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer®

Retrieved on: 
Thursday, February 8, 2024
Science, Other Science, Research, Medical Supplies, Health, Medical Devices, Clinical Trials, Other Health, NAO, ENT, Randomized controlled trial, Nasal congestion, Somnolence, Eastern Virginia Medical School, Nose, Exercise, Physician, Multimedia, Ear, Allergy, Patient, Network congestion, Pharmaceutical industry

Aerin Medical Inc. , a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced that Rhinology Journal has published positive two-year outcomes from the VATRAC trial.

Key Points: 
  • Aerin Medical Inc. , a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced that Rhinology Journal has published positive two-year outcomes from the VATRAC trial.
  • Previously published three-month results of the randomized controlled trial demonstrated that treatment with VivAer was safe and superior to a sham procedure.1
    This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20240208997581/en/
    Two-year outcomes from the VATRAC trial published in Rhinology Journal confirm that treatment with VivAer® resulted in significant and lasting improvements in nasal obstruction symptoms.
  • This publication adds to a deep dossier of clinical evidence for VivAer, with three separate studies now confirming multi-year durability.

SightMD Pennsylvania Welcomes David L. Silverman, MD to its Expert Team

Retrieved on: 
Monday, February 5, 2024
Greater Baltimore Medical Center, History, Fear, Language, MD, Teaching, Ageing, Patient, American Academy, Love, Microsurgery, Disease, UTHealth School of Dentistry, Eastern Virginia Medical School, Health, Medicine, University, Eye, Internal medicine, Private practice

HAUPPAUGE, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.

Key Points: 
  • SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.
  • HAUPPAUGE, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.
  • David L. Silverman, MD has been practicing comprehensive ophthalmology for nearly 30 years.
  • He is board certified by the American Board of Ophthalmology and is an active fellow of the American Academy of Ophthalmology.

First Fertility Appoints New Chief Scientific Officer

Retrieved on: 
Wednesday, January 3, 2024
Women, Biotechnology, Managed Care, General Health, Health, Family, Baby, Maternity, Consumer, Advancement, Pregnancy, Multimedia, Fertility, Research, ART, Reproductive medicine, College, Eastern Virginia Medical School, Laboratory, University, Society, Abstract, Andrology, Doctor of Philosophy, Patient, Publication, Risk management, Cell biology, Nursing

First Fertility , one of the largest fertility networks in the United States announced today that Alison Bartolucci, Ph.D., HCLD has been appointed as Chief Scientific Officer, furthering the company’s mission to exceed the standard of fertility care by providing compassionate, customized services with the highest quality of innovative and evidence-based reproductive technology and treatments.

Key Points: 
  • First Fertility , one of the largest fertility networks in the United States announced today that Alison Bartolucci, Ph.D., HCLD has been appointed as Chief Scientific Officer, furthering the company’s mission to exceed the standard of fertility care by providing compassionate, customized services with the highest quality of innovative and evidence-based reproductive technology and treatments.
  • In her role as the First Fertility Chief Scientific Officer, Dr. Bartolucci will lead embryology, andrology, and endocrinology lab initiatives across the First Fertility network focused on measuring and improving pregnancy outcomes and advancing scientific research, as well as compliance and risk management.
  • "I am beyond excited and honored to continue working with this organization in my new role as Chief Scientific Officer.
  • “I’m delighted that Alison has accepted the position of Chief Scientific Officer for First Fertility.

Eastern Virginia Medical School Student Receives SBB Research Group Foundation STEM Scholarship

Retrieved on: 
Wednesday, November 22, 2023
STEM, Northwestern University, Learning, Student, Stroke, Neurosurgery, Manuscript, Eastern Virginia Medical School, Nursing, Mathematics, Science, Engineering

CHICAGO, Nov. 22, 2023 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Aravind Sreeram a recipient of its STEM scholarship. The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).

Key Points: 
  • CHICAGO, Nov. 22, 2023 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Aravind Sreeram a recipient of its STEM scholarship.
  • The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).
  • Aravind, a first-year medical student, studies at Eastern Virginia Medical School.
  • "We are happy to support Aravind in his pursuit of a medical degree and his work to make meaningful contributions to the field," said Matt Aven, co-founder and board member of the SBB Research Group Foundation.

First Randomized Controlled Trial Comparing Woebot to Clinician-Led Psychotherapy Reveals Digital Mental Health Intervention Is Non-Inferior in Reducing Depressive Symptoms Among Teens

Retrieved on: 
Thursday, October 26, 2023
Mental Health, Health, Consumer, Apps, Applications, Technology, Teens, Cognitive behavioral therapy, Adolescence, Triage, Mental, Clinical trial, MD, Journal of the American Academy of Child and Adolescent Psychiatry, Doctor of Philosophy, Research, CHKD, Multimedia, Pediatrics, Union, White, American Academy, AACAP, Eastern Virginia Medical School, African Americans, CBT, Safety, Depression, Anxiety, Bentham Science Publishers, Patient, Grammatical mood, Patient Health Questionnaire, Mental health, Nursing, Child

The results were presented in a poster presentation at the American Academy of Child and Adolescent Psychiatry ( AACAP ) conference.

Key Points: 
  • The results were presented in a poster presentation at the American Academy of Child and Adolescent Psychiatry ( AACAP ) conference.
  • View the full release here: https://www.businesswire.com/news/home/20231026083262/en/
    This is the first known study to compare an agent-based digital mental health intervention to a therapist-led therapeutic intervention in a real-world clinical setting.
  • The findings suggest a potential role for W-GenZD within outpatient mental health care clinics to address the ongoing adolescent mental health crisis.
  • A non-inferiority test was used to evaluate the study aim comparing the reduction in PHQ-8-measured depression symptoms between the two interventions at the end of treatment.

REST Technologies INC breakthrough technologies help monitor pregnant women for dangerous sleep disorders.

Retrieved on: 
Friday, September 8, 2023
Pregnancy, Eclampsia, Prevalence, Sleep, Eastern Virginia Medical School, Gestational diabetes, SBIR, Prenatal care, National Heart, Lung, and Blood Institute, Dean (education), CSMA, Woman, Sleep apnea, Research, OSA, Lung, Associate, Bangladesh Technical Education Board, Harvard Medical School, Hypertension, Tracker, Professor, MD, REST, National Institute for Health and Care Excellence, Patient, Risk, Physician, Small Business Innovation Research, Pre-eclampsia, Disease, Gynaecology, Mortality, Association of Women's Health, Obstetric and Neonatal Nurses, Remote patient monitoring, Transport, Health, RPM, BMI, FDA, Obstructive sleep apnea, NIH, Chair, Pharmaceutical industry, Nursing, Dietary supplement, Medical device, Medicine

HOUSTON, Sept. 8, 2023 /PRNewswire-PRWeb/ -- The National Institute of Health (NIH) awards REST Technologies, Inc. (REST), a Small Business Innovation Research (SBIR) grant to demonstrate the ability to monitor sleep in pregnant women nightly, to identify the onset of obstructive sleep apnea (OSA), which could improve outcomes in high-risk obstetric patients. This is done by using the REST Tracker platform, developed by REST Technologies, Inc., that incorporates home sleep testing technology, developed by SleepImage which obtains data from a ring when asleep.

Key Points: 
  • HOUSTON, Sept. 8, 2023 /PRNewswire-PRWeb/ -- The National Institute of Health (NIH) awards REST Technologies, Inc. (REST) , a Small Business Innovation Research (SBIR) grant to demonstrate the ability to monitor sleep in pregnant women nightly, to identify the onset of obstructive sleep apnea (OSA), which could improve outcomes in high-risk obstetric patients.
  • This is done by using the REST Tracker platform , developed by REST Technologies, Inc .
  • REST Technologies, Inc.'s founding CEO, Jerald Simmons, MD appreciated the need to capture the sleep data and its important clinical value.
  • Now RPM wearable devices can be easily accessed by physicians, medical groups and industries with the REST Tracker by REST Technologies, to manage their users, assisting the outcomes for better sleep.

Aimee DeGaetano Joins Vastrax as Global Head of Commercial and Clinical Affairs

Retrieved on: 
Thursday, August 31, 2023
Health, Neurology, Clinical Trials, Cardiology, Eastern Virginia Medical School, Commercial, Patient, RD, Contract research organization, Public, Nursing

Vastrax, a premier full-service Contract Research Organization (CRO) with a mission to expedite the development of cutting-edge technologies in the vascular market, proudly announces the appointment of Aimee DeGaetano as the Global Head of Commercial and Clinical Affairs.

Key Points: 
  • Vastrax, a premier full-service Contract Research Organization (CRO) with a mission to expedite the development of cutting-edge technologies in the vascular market, proudly announces the appointment of Aimee DeGaetano as the Global Head of Commercial and Clinical Affairs.
  • "Aimee's expertise aligns seamlessly with our mission, and we are thrilled to have her lead our Global Commercial Strategy and Clinical Affairs.
  • Aimee's appointment comes at a crucial juncture in Vastrax's journey as we continue to lead the way in neurovascular clinical trials.
  • She has held various leadership roles in medical technology companies, focusing on clinical trials, medical affairs, and key opinion leader engagement.

Dr. Alexander Song Joins Los Angeles Cancer Network

Retrieved on: 
Thursday, August 3, 2023
Parable of the Good Samaritan, Internal medicine, Immunotherapy, Atrium Health Wake Forest Baptist, Oncology, Eastern Virginia Medical School, MD, Physician, Patient, Hematology, Nursing, Medical device

LOS ANGELES, Aug. 3, 2023 /PRNewswire/ -- Los Angeles Cancer Network (LACN), one of the leading cancer and blood disorder centers in Los Angeles, is proud to announce that Alexander Song, MD has officially joined its growing network.

Key Points: 
  • LOS ANGELES, Aug. 3, 2023 /PRNewswire/ -- Los Angeles Cancer Network (LACN), one of the leading cancer and blood disorder centers in Los Angeles, is proud to announce that Alexander Song, MD has officially joined its growing network.
  • He will be practicing at LACN's Hollywood Presbyterian [1300 N. Vermont Ave. Los Angeles, CA 90027] and Good Samaritan [1245 Wilshire Blvd.
  • Suite 303, Los Angeles, CA 90017] clinics.
  • "I am excited to join Los Angeles Cancer Network," said Dr. Song, "because I will be able to provide compassionate and individualized care, work next to some of the best physicians in the nation and have access to cutting-edge clinical trials so I can better serve my patients.